Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis
Purpose: Multiple sclerosis (MS) is a debilitating neuroinflammatory disorder of the central nervous system. It is believed to result from an impaired immune response against myelin components especially myelin oligodendrocyte glycoprotein (MOG). Some efforts have been made to bioconjugate the MOG p...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tabriz University of Medical Sciences
2021-06-01
|
| Series: | Advanced Pharmaceutical Bulletin |
| Subjects: | |
| Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-11-505.pdf |
| _version_ | 1819349650734317568 |
|---|---|
| author | Mehrdad Gholamzad Hussein Baharlooi Mehdi Shafiee Ardestani Zeinab Seyedkhan Maryam Azimi |
| author_facet | Mehrdad Gholamzad Hussein Baharlooi Mehdi Shafiee Ardestani Zeinab Seyedkhan Maryam Azimi |
| author_sort | Mehrdad Gholamzad |
| collection | DOAJ |
| description | Purpose: Multiple sclerosis (MS) is a debilitating neuroinflammatory disorder of the central nervous system. It is believed to result from an impaired immune response against myelin components especially myelin oligodendrocyte glycoprotein (MOG). Some efforts have been made to bioconjugate the MOG peptides to tolerogenic particles like poly (lactic-co-glycolic acid) (PLGA) for treating animal models of autoimmune disorders. Accordingly, we aimed to elucidate the tolerogenic effects of MOG-PLGA particles on experimental autoimmune encephalomyelitis (EAE). Methods: PGLA nanoparticles were synthesized using water/oil/water procedure. Next, the MOG or ovalbumin (OVA) peptides covalently linked to the PLGA particles. These particles were then intravenously or subcutaneously administered to nine groups of C57BL/6 mice before and after EAE induction. The brain tissues were assessed for the infiltration of immune cells. The Tolerogenic effect of the vaccine was also assessed on the quantity of the Treg cells. Moreover, the amount of interferon-γ (IFN-γ), interleukin-10 (IL-10), and interleukin-17 levels produced by splenic lymphocytes were then quantified by ELISA. Results: Intravenous administration of PLGA500-MOG35-55 nanoparticles before EAE induction ameliorated EAE clinical scores as well as infiltration of immune cells into the brain. In the spleen, the treatment increased CD4+CD25+FoxP3+ Treg population and restored the homeostasis of IFN-γ, IL-10, and IL-17 (all P values <0.0001) among splenocytes. Conclusion: The conjugation of MOG peptides to the PLGA nanoparticles significantly recovered clinical symptoms and the autoimmune response of EAE. The MOG-PGLA particles are potentially valuable for further evaluations, hopefully progressing toward an optimal approach that can be translated to the clinic. |
| first_indexed | 2024-12-24T19:03:54Z |
| format | Article |
| id | doaj.art-06ce98cfba274e44a5e716c56d4101b3 |
| institution | Directory Open Access Journal |
| issn | 2228-5881 2251-7308 |
| language | English |
| last_indexed | 2024-12-24T19:03:54Z |
| publishDate | 2021-06-01 |
| publisher | Tabriz University of Medical Sciences |
| record_format | Article |
| series | Advanced Pharmaceutical Bulletin |
| spelling | doaj.art-06ce98cfba274e44a5e716c56d4101b32022-12-21T16:43:08ZengTabriz University of Medical SciencesAdvanced Pharmaceutical Bulletin2228-58812251-73082021-06-0111350551310.34172/apb.2021.058apb-28519Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple SclerosisMehrdad Gholamzad0Hussein Baharlooi1Mehdi Shafiee Ardestani2Zeinab Seyedkhan3Maryam Azimi4Department of Microbiology and Immunology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.Department of Biology, College of Basic Science, Tehran Science and Research Branch, Islamic Azad University, Tehran, Iran.Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.Purpose: Multiple sclerosis (MS) is a debilitating neuroinflammatory disorder of the central nervous system. It is believed to result from an impaired immune response against myelin components especially myelin oligodendrocyte glycoprotein (MOG). Some efforts have been made to bioconjugate the MOG peptides to tolerogenic particles like poly (lactic-co-glycolic acid) (PLGA) for treating animal models of autoimmune disorders. Accordingly, we aimed to elucidate the tolerogenic effects of MOG-PLGA particles on experimental autoimmune encephalomyelitis (EAE). Methods: PGLA nanoparticles were synthesized using water/oil/water procedure. Next, the MOG or ovalbumin (OVA) peptides covalently linked to the PLGA particles. These particles were then intravenously or subcutaneously administered to nine groups of C57BL/6 mice before and after EAE induction. The brain tissues were assessed for the infiltration of immune cells. The Tolerogenic effect of the vaccine was also assessed on the quantity of the Treg cells. Moreover, the amount of interferon-γ (IFN-γ), interleukin-10 (IL-10), and interleukin-17 levels produced by splenic lymphocytes were then quantified by ELISA. Results: Intravenous administration of PLGA500-MOG35-55 nanoparticles before EAE induction ameliorated EAE clinical scores as well as infiltration of immune cells into the brain. In the spleen, the treatment increased CD4+CD25+FoxP3+ Treg population and restored the homeostasis of IFN-γ, IL-10, and IL-17 (all P values <0.0001) among splenocytes. Conclusion: The conjugation of MOG peptides to the PLGA nanoparticles significantly recovered clinical symptoms and the autoimmune response of EAE. The MOG-PGLA particles are potentially valuable for further evaluations, hopefully progressing toward an optimal approach that can be translated to the clinic.https://apb.tbzmed.ac.ir/PDF/apb-11-505.pdfmultiple sclerosisexperimental autoimmune encephalomyelitismyelin oligodendrocyte glycoproteinpoly (lactic-co-glycolic acid)regulatory t cellimmune tolerancebiomaterials |
| spellingShingle | Mehrdad Gholamzad Hussein Baharlooi Mehdi Shafiee Ardestani Zeinab Seyedkhan Maryam Azimi Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis Advanced Pharmaceutical Bulletin multiple sclerosis experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein poly (lactic-co-glycolic acid) regulatory t cell immune tolerance biomaterials |
| title | Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis |
| title_full | Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis |
| title_fullStr | Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis |
| title_full_unstemmed | Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis |
| title_short | Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis |
| title_sort | prophylactic and therapeutic effects of mog conjugated plga nanoparticles in c57bl 6 mouse model of multiple sclerosis |
| topic | multiple sclerosis experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein poly (lactic-co-glycolic acid) regulatory t cell immune tolerance biomaterials |
| url | https://apb.tbzmed.ac.ir/PDF/apb-11-505.pdf |
| work_keys_str_mv | AT mehrdadgholamzad prophylacticandtherapeuticeffectsofmogconjugatedplgananoparticlesinc57bl6mousemodelofmultiplesclerosis AT husseinbaharlooi prophylacticandtherapeuticeffectsofmogconjugatedplgananoparticlesinc57bl6mousemodelofmultiplesclerosis AT mehdishafieeardestani prophylacticandtherapeuticeffectsofmogconjugatedplgananoparticlesinc57bl6mousemodelofmultiplesclerosis AT zeinabseyedkhan prophylacticandtherapeuticeffectsofmogconjugatedplgananoparticlesinc57bl6mousemodelofmultiplesclerosis AT maryamazimi prophylacticandtherapeuticeffectsofmogconjugatedplgananoparticlesinc57bl6mousemodelofmultiplesclerosis |